APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coartem (Artemether & Lumefantrine)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Coartem (Artemether & Lumefantrine) Market Analysis and Forecast 2026-2032

21 December 2025192 pages

Choose your research edition.

Industry ResearchCoartem (Artemether & Lumefantrine) Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Coartem (Artemether & Lumefantrine) Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Coartem (Artemether & Lumefantrine) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coartem (Artemether & Lumefantrine) Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Coartem (Artemether & Lumefantrine) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Coartem (Artemether & Lumefantrine) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Coartem (Artemether & Lumefantrine) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Coartem (Artemether & Lumefantrine) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Coartem (Artemether & Lumefantrine) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Coartem (Artemether & Lumefantrine) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Coartem (Artemether & Lumefantrine) include Novartis, Kunming Pharmaceutical, Kerui Nanhai Pharmaceutical, Guilin Pharmaceutical Co., Ltd, Guangxi Xiancaotang Pharmaceutical Co., LTD, Sanofi-Aventis and KPC Pharmaceuticals, Inc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Coartem (Artemether & Lumefantrine), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Coartem (Artemether & Lumefantrine), also provides the sales of main regions and countries. Of the upcoming market potential for Coartem (Artemether & Lumefantrine), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Coartem (Artemether & Lumefantrine) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Coartem (Artemether & Lumefantrine) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Coartem (Artemether & Lumefantrine) sales, projected growth trends, production technology, application and end-user industry.

Coartem (Artemether & Lumefantrine) Segment by Company

Novartis

Kunming Pharmaceutical

Kerui Nanhai Pharmaceutical

Guilin Pharmaceutical Co., Ltd

Guangxi Xiancaotang Pharmaceutical Co., LTD

Sanofi-Aventis

KPC Pharmaceuticals, Inc

Coartem (Artemether & Lumefantrine) Segment by Type

Artemether

Lumefantrine

Coartem (Artemether & Lumefantrine) Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Coartem (Artemether & Lumefantrine) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coartem (Artemether & Lumefantrine) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coartem (Artemether & Lumefantrine) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coartem (Artemether & Lumefantrine).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Coartem (Artemether & Lumefantrine) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Coartem (Artemether & Lumefantrine) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Coartem (Artemether & Lumefantrine) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Coartem (Artemether & Lumefantrine) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Artemether Major Manufacturers Table 3. Lumefantrine Major Manufacturers Table 4. Global Coartem (Artemether & Lumefantrine) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Retail Pharmacy Major Manufacturers Table 6. Online Pharmacy Major Manufacturers Table 7. Hospital Pharmacy Major Manufacturers Table 8. Coartem (Artemether & Lumefantrine) Industry Trends Table 9. Coartem (Artemether & Lumefantrine) Industry Drivers Table 10. Coartem (Artemether & Lumefantrine) Industry Opportunities and Challenges Table 11. Coartem (Artemether & Lumefantrine) Industry Restraints Table 12. Global Coartem (Artemether & Lumefantrine) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Coartem (Artemether & Lumefantrine) Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Coartem (Artemether & Lumefantrine) Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Region (2021-2026) Table 16. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Region (2027-2032) Table 17. Global Coartem (Artemether & Lumefantrine) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Coartem (Artemether & Lumefantrine) Sales by Region (2021-2026) & (k units) Table 19. Global Coartem (Artemether & Lumefantrine) Sales by Region (2027-2032) & (k units) Table 20. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Region (2021-2026) Table 21. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Region (2027-2032) Table 22. Global Coartem (Artemether & Lumefantrine) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Coartem (Artemether & Lumefantrine) Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Manufacturers (2021-2026) Table 26. Global Coartem (Artemether & Lumefantrine) Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Coartem (Artemether & Lumefantrine) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Coartem (Artemether & Lumefantrine) Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Coartem (Artemether & Lumefantrine) Manufacturers, Product Type & Application Table 30. Global Coartem (Artemether & Lumefantrine) Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Coartem (Artemether & Lumefantrine) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Coartem (Artemether & Lumefantrine) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Coartem (Artemether & Lumefantrine) Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Coartem (Artemether & Lumefantrine) Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Type (2021-2026) Table 37. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Type (2027-2032) Table 38. Global Coartem (Artemether & Lumefantrine) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Coartem (Artemether & Lumefantrine) Sales by Type (2021-2026) & (k units) Table 40. Global Coartem (Artemether & Lumefantrine) Sales by Type (2027-2032) & (k units) Table 41. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Type (2021-2026) Table 42. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Type (2027-2032) Table 43. Global Coartem (Artemether & Lumefantrine) Price by Type (2021-2026) & (US$/unit) Table 44. Global Coartem (Artemether & Lumefantrine) Price by Type (2027-2032) & (US$/unit) Table 45. Global Coartem (Artemether & Lumefantrine) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Coartem (Artemether & Lumefantrine) Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Coartem (Artemether & Lumefantrine) Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Application (2021-2026) Table 49. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Application (2027-2032) Table 50. Global Coartem (Artemether & Lumefantrine) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Coartem (Artemether & Lumefantrine) Sales by Application (2021-2026) & (k units) Table 52. Global Coartem (Artemether & Lumefantrine) Sales by Application (2027-2032) & (k units) Table 53. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Application (2021-2026) Table 54. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Application (2027-2032) Table 55. Global Coartem (Artemether & Lumefantrine) Price by Application (2021-2026) & (US$/unit) Table 56. Global Coartem (Artemether & Lumefantrine) Price by Application (2027-2032) & (US$/unit) Table 57. Novartis Company Information Table 58. Novartis Business Overview Table 59. Novartis Coartem (Artemether & Lumefantrine) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Novartis Coartem (Artemether & Lumefantrine) Product Portfolio Table 61. Novartis Recent Development Table 62. Kunming Pharmaceutical Company Information Table 63. Kunming Pharmaceutical Business Overview Table 64. Kunming Pharmaceutical Coartem (Artemether & Lumefantrine) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Kunming Pharmaceutical Coartem (Artemether & Lumefantrine) Product Portfolio Table 66. Kunming Pharmaceutical Recent Development Table 67. Kerui Nanhai Pharmaceutical Company Information Table 68. Kerui Nanhai Pharmaceutical Business Overview Table 69. Kerui Nanhai Pharmaceutical Coartem (Artemether & Lumefantrine) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Kerui Nanhai Pharmaceutical Coartem (Artemether & Lumefantrine) Product Portfolio Table 71. Kerui Nanhai Pharmaceutical Recent Development Table 72. Guilin Pharmaceutical Co., Ltd Company Information Table 73. Guilin Pharmaceutical Co., Ltd Business Overview Table 74. Guilin Pharmaceutical Co., Ltd Coartem (Artemether & Lumefantrine) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Guilin Pharmaceutical Co., Ltd Coartem (Artemether & Lumefantrine) Product Portfolio Table 76. Guilin Pharmaceutical Co., Ltd Recent Development Table 77. Guangxi Xiancaotang Pharmaceutical Co., LTD Company Information Table 78. Guangxi Xiancaotang Pharmaceutical Co., LTD Business Overview Table 79. Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether & Lumefantrine) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether & Lumefantrine) Product Portfolio Table 81. Guangxi Xiancaotang Pharmaceutical Co., LTD Recent Development Table 82. Sanofi-Aventis Company Information Table 83. Sanofi-Aventis Business Overview Table 84. Sanofi-Aventis Coartem (Artemether & Lumefantrine) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Sanofi-Aventis Coartem (Artemether & Lumefantrine) Product Portfolio Table 86. Sanofi-Aventis Recent Development Table 87. KPC Pharmaceuticals, Inc Company Information Table 88. KPC Pharmaceuticals, Inc Business Overview Table 89. KPC Pharmaceuticals, Inc Coartem (Artemether & Lumefantrine) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. KPC Pharmaceuticals, Inc Coartem (Artemether & Lumefantrine) Product Portfolio Table 91. KPC Pharmaceuticals, Inc Recent Development Table 92. North America Coartem (Artemether & Lumefantrine) Revenue by Type (2021-2026) & (US$ Million) Table 93. North America Coartem (Artemether & Lumefantrine) Revenue by Type (2027-2032) & (US$ Million) Table 94. North America Coartem (Artemether & Lumefantrine) Sales by Type (2021-2026) & (k units) Table 95. North America Coartem (Artemether & Lumefantrine) Sales by Type (2027-2032) & (k units) Table 96. North America Coartem (Artemether & Lumefantrine) Sales Price by Type (2021-2026) & (US$/unit) Table 97. North America Coartem (Artemether & Lumefantrine) Sales Price by Type (2027-2032) & (US$/unit) Table 98. North America Coartem (Artemether & Lumefantrine) Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Coartem (Artemether & Lumefantrine) Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Coartem (Artemether & Lumefantrine) Sales by Application (2021-2026) & (k units) Table 101. North America Coartem (Artemether & Lumefantrine) Sales by Application (2027-2032) & (k units) Table 102. North America Coartem (Artemether & Lumefantrine) Sales Price by Application (2021-2026) & (US$/unit) Table 103. North America Coartem (Artemether & Lumefantrine) Sales Price by Application (2027-2032) & (US$/unit) Table 104. North America Coartem (Artemether & Lumefantrine) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Coartem (Artemether & Lumefantrine) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 106. North America Coartem (Artemether & Lumefantrine) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 107. North America Coartem (Artemether & Lumefantrine) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 108. North America Coartem (Artemether & Lumefantrine) Sales by Country (2021-2026) & (k units) Table 109. North America Coartem (Artemether & Lumefantrine) Sales by Country (2027-2032) & (k units) Table 110. North America Coartem (Artemether & Lumefantrine) Sales Price by Country (2021-2026) & (US$/unit) Table 111. North America Coartem (Artemether & Lumefantrine) Sales Price by Country (2027-2032) & (US$/unit) Table 112. United States Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 113. Canada Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 114. Mexico Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 115. Europe Coartem (Artemether & Lumefantrine) Revenue by Type (2021-2026) & (US$ Million) Table 116. Europe Coartem (Artemether & Lumefantrine) Revenue by Type (2027-2032) & (US$ Million) Table 117. Europe Coartem (Artemether & Lumefantrine) Sales by Type (2021-2026) & (k units) Table 118. Europe Coartem (Artemether & Lumefantrine) Sales by Type (2027-2032) & (k units) Table 119. Europe Coartem (Artemether & Lumefantrine) Sales Price by Type (2021-2026) & (US$/unit) Table 120. Europe Coartem (Artemether & Lumefantrine) Sales Price by Type (2027-2032) & (US$/unit) Table 121. Europe Coartem (Artemether & Lumefantrine) Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe Coartem (Artemether & Lumefantrine) Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe Coartem (Artemether & Lumefantrine) Sales by Application (2021-2026) & (k units) Table 124. Europe Coartem (Artemether & Lumefantrine) Sales by Application (2027-2032) & (k units) Table 125. Europe Coartem (Artemether & Lumefantrine) Sales Price by Application (2021-2026) & (US$/unit) Table 126. Europe Coartem (Artemether & Lumefantrine) Sales Price by Application (2027-2032) & (US$/unit) Table 127. Europe Coartem (Artemether & Lumefantrine) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe Coartem (Artemether & Lumefantrine) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 129. Europe Coartem (Artemether & Lumefantrine) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 130. Europe Coartem (Artemether & Lumefantrine) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 131. Europe Coartem (Artemether & Lumefantrine) Sales by Country (2021-2026) & (k units) Table 132. Europe Coartem (Artemether & Lumefantrine) Sales by Country (2027-2032) & (k units) Table 133. Europe Coartem (Artemether & Lumefantrine) Sales Price by Country (2021-2026) & (US$/unit) Table 134. Europe Coartem (Artemether & Lumefantrine) Sales Price by Country (2027-2032) & (US$/unit) Table 135. Germany Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 136. France Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 137. U.K. Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 138. Italy Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 139. Russia Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 140. Spain Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 141. Netherlands Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 142. Switzerland Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 143. Sweden Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 144. Poland Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 145. China Coartem (Artemether & Lumefantrine) Revenue by Type (2021-2026) & (US$ Million) Table 146. China Coartem (Artemether & Lumefantrine) Revenue by Type (2027-2032) & (US$ Million) Table 147. China Coartem (Artemether & Lumefantrine) Sales by Type (2021-2026) & (k units) Table 148. China Coartem (Artemether & Lumefantrine) Sales by Type (2027-2032) & (k units) Table 149. China Coartem (Artemether & Lumefantrine) Sales Price by Type (2021-2026) & (US$/unit) Table 150. China Coartem (Artemether & Lumefantrine) Sales Price by Type (2027-2032) & (US$/unit) Table 151. China Coartem (Artemether & Lumefantrine) Revenue by Application (2021-2026) & (US$ Million) Table 152. China Coartem (Artemether & Lumefantrine) Revenue by Application (2027-2032) & (US$ Million) Table 153. China Coartem (Artemether & Lumefantrine) Sales by Application (2021-2026) & (k units) Table 154. China Coartem (Artemether & Lumefantrine) Sales by Application (2027-2032) & (k units) Table 155. China Coartem (Artemether & Lumefantrine) Sales Price by Application (2021-2026) & (US$/unit) Table 156. China Coartem (Artemether & Lumefantrine) Sales Price by Application (2027-2032) & (US$/unit) Table 157. Asia Coartem (Artemether & Lumefantrine) Revenue by Type (2021-2026) & (US$ Million) Table 158. Asia Coartem (Artemether & Lumefantrine) Revenue by Type (2027-2032) & (US$ Million) Table 159. Asia Coartem (Artemether & Lumefantrine) Sales by Type (2021-2026) & (k units) Table 160. Asia Coartem (Artemether & Lumefantrine) Sales by Type (2027-2032) & (k units) Table 161. Asia Coartem (Artemether & Lumefantrine) Sales Price by Type (2021-2026) & (US$/unit) Table 162. Asia Coartem (Artemether & Lumefantrine) Sales Price by Type (2027-2032) & (US$/unit) Table 163. Asia Coartem (Artemether & Lumefantrine) Revenue by Application (2021-2026) & (US$ Million) Table 164. Asia Coartem (Artemether & Lumefantrine) Revenue by Application (2027-2032) & (US$ Million) Table 165. Asia Coartem (Artemether & Lumefantrine) Sales by Application (2021-2026) & (k units) Table 166. Asia Coartem (Artemether & Lumefantrine) Sales by Application (2027-2032) & (k units) Table 167. Asia Coartem (Artemether & Lumefantrine) Sales Price by Application (2021-2026) & (US$/unit) Table 168. Asia Coartem (Artemether & Lumefantrine) Sales Price by Application (2027-2032) & (US$/unit) Table 169. Asia Coartem (Artemether & Lumefantrine) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Asia Coartem (Artemether & Lumefantrine) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. Asia Coartem (Artemether & Lumefantrine) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. Asia Coartem (Artemether & Lumefantrine) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 173. Asia Coartem (Artemether & Lumefantrine) Sales by Country (2021-2026) & (k units) Table 174. Asia Coartem (Artemether & Lumefantrine) Sales by Country (2027-2032) & (k units) Table 175. Asia Coartem (Artemether & Lumefantrine) Sales Price by Country (2021-2026) & (US$/unit) Table 176. Asia Coartem (Artemether & Lumefantrine) Sales Price by Country (2027-2032) & (US$/unit) Table 177. Japan Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 178. South Korea Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 179. India Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 180. Australia Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 181. Taiwan Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 182. Southeast Asia Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 183. SAMEA Coartem (Artemether & Lumefantrine) Revenue by Type (2021-2026) & (US$ Million) Table 184. SAMEA Coartem (Artemether & Lumefantrine) Revenue by Type (2027-2032) & (US$ Million) Table 185. SAMEA Coartem (Artemether & Lumefantrine) Sales by Type (2021-2026) & (k units) Table 186. SAMEA Coartem (Artemether & Lumefantrine) Sales by Type (2027-2032) & (k units) Table 187. SAMEA Coartem (Artemether & Lumefantrine) Sales Price by Type (2021-2026) & (US$/unit) Table 188. SAMEA Coartem (Artemether & Lumefantrine) Sales Price by Type (2027-2032) & (US$/unit) Table 189. SAMEA Coartem (Artemether & Lumefantrine) Revenue by Application (2021-2026) & (US$ Million) Table 190. SAMEA Coartem (Artemether & Lumefantrine) Revenue by Application (2027-2032) & (US$ Million) Table 191. SAMEA Coartem (Artemether & Lumefantrine) Sales by Application (2021-2026) & (k units) Table 192. SAMEA Coartem (Artemether & Lumefantrine) Sales by Application (2027-2032) & (k units) Table 193. SAMEA Coartem (Artemether & Lumefantrine) Sales Price by Application (2021-2026) & (US$/unit) Table 194. SAMEA Coartem (Artemether & Lumefantrine) Sales Price by Application (2027-2032) & (US$/unit) Table 195. SAMEA Coartem (Artemether & Lumefantrine) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. SAMEA Coartem (Artemether & Lumefantrine) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. SAMEA Coartem (Artemether & Lumefantrine) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. SAMEA Coartem (Artemether & Lumefantrine) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 199. SAMEA Coartem (Artemether & Lumefantrine) Sales by Country (2021-2026) & (k units) Table 200. SAMEA Coartem (Artemether & Lumefantrine) Sales by Country (2027-2032) & (k units) Table 201. SAMEA Coartem (Artemether & Lumefantrine) Sales Price by Country (2021-2026) & (US$/unit) Table 202. SAMEA Coartem (Artemether & Lumefantrine) Sales Price by Country (2027-2032) & (US$/unit) Table 203. Brazil Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 204. Argentina Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 205. Chile Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 206. Colombia Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 207. Peru Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 208. Saudi Arabia Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 209. Israel Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 210. UAE Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 211. Turkey Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 212. Iran Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 213. Egypt Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. Coartem (Artemether & Lumefantrine) Distributors List Table 217. Coartem (Artemether & Lumefantrine) Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. Coartem (Artemether & Lumefantrine) Image Figure 2. Global Coartem (Artemether & Lumefantrine) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Coartem (Artemether & Lumefantrine) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Artemether Image Figure 5. Lumefantrine Image Figure 6. Global Coartem (Artemether & Lumefantrine) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Coartem (Artemether & Lumefantrine) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Retail Pharmacy Image Figure 9. Online Pharmacy Image Figure 10. Hospital Pharmacy Image Figure 11. Global Coartem (Artemether & Lumefantrine) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Figure 13. Global Coartem (Artemether & Lumefantrine) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Region (2021-2032) Figure 16. Global Coartem (Artemether & Lumefantrine) Sales (2021-2032) & (k units) Figure 17. Global Coartem (Artemether & Lumefantrine) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Coartem (Artemether & Lumefantrine) Sales YoY (2021-2032) & (k units) Figure 20. Europe Coartem (Artemether & Lumefantrine) Sales YoY (2021-2032) & (k units) Figure 21. China Coartem (Artemether & Lumefantrine) Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Coartem (Artemether & Lumefantrine) Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Coartem (Artemether & Lumefantrine) Sales YoY (2021-2032) & (k units) Figure 24. Global Coartem (Artemether & Lumefantrine) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Coartem (Artemether & Lumefantrine) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Coartem (Artemether & Lumefantrine) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Type (2021-2032) Figure 30. Global Coartem (Artemether & Lumefantrine) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Type (2021-2032) Figure 33. Global Coartem (Artemether & Lumefantrine) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Application (2021-2032) Figure 36. Global Coartem (Artemether & Lumefantrine) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Application (2021-2032) Figure 39. North America Coartem (Artemether & Lumefantrine) Revenue Share by Type (2021-2032) Figure 40. North America Coartem (Artemether & Lumefantrine) Sales Share by Type (2021-2032) Figure 41. North America Coartem (Artemether & Lumefantrine) Revenue Share by Application (2021-2032) Figure 42. North America Coartem (Artemether & Lumefantrine) Sales Share by Application (2021-2032) Figure 43. North America Coartem (Artemether & Lumefantrine) Revenue Share by Country (2021-2032) Figure 44. North America Coartem (Artemether & Lumefantrine) Sales Share by Country (2021-2032) Figure 45. Europe Coartem (Artemether & Lumefantrine) Revenue Share by Type (2021-2032) Figure 46. Europe Coartem (Artemether & Lumefantrine) Sales Share by Type (2021-2032) Figure 47. Europe Coartem (Artemether & Lumefantrine) Revenue Share by Application (2021-2032) Figure 48. Europe Coartem (Artemether & Lumefantrine) Sales Share by Application (2021-2032) Figure 49. Europe Coartem (Artemether & Lumefantrine) Revenue Share by Country (2021-2032) Figure 50. Europe Coartem (Artemether & Lumefantrine) Sales Share by Country (2021-2032) Figure 51. China Coartem (Artemether & Lumefantrine) Revenue Share by Type (2021-2032) Figure 52. China Coartem (Artemether & Lumefantrine) Sales Share by Type (2021-2032) Figure 53. China Coartem (Artemether & Lumefantrine) Revenue Share by Application (2021-2032) Figure 54. China Coartem (Artemether & Lumefantrine) Sales Share by Application (2021-2032) Figure 55. Asia Coartem (Artemether & Lumefantrine) Revenue Share by Type (2021-2032) Figure 56. Asia Coartem (Artemether & Lumefantrine) Sales Share by Type (2021-2032) Figure 57. Asia Coartem (Artemether & Lumefantrine) Revenue Share by Application (2021-2032) Figure 58. Asia Coartem (Artemether & Lumefantrine) Sales Share by Application (2021-2032) Figure 59. Asia Coartem (Artemether & Lumefantrine) Revenue Share by Country (2021-2032) Figure 60. Asia Coartem (Artemether & Lumefantrine) Sales Share by Country (2021-2032) Figure 61. SAMEA Coartem (Artemether & Lumefantrine) Revenue Share by Type (2021-2032) Figure 62. SAMEA Coartem (Artemether & Lumefantrine) Sales Share by Type (2021-2032) Figure 63. SAMEA Coartem (Artemether & Lumefantrine) Revenue Share by Application (2021-2032) Figure 64. SAMEA Coartem (Artemether & Lumefantrine) Sales Share by Application (2021-2032) Figure 65. SAMEA Coartem (Artemether & Lumefantrine) Revenue Share by Country (2021-2032) Figure 66. SAMEA Coartem (Artemether & Lumefantrine) Sales Share by Country (2021-2032) Figure 67. Coartem (Artemether & Lumefantrine) Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Coartem (Artemether & Lumefantrine) Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Artemether
  • Lumefantrine
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
Companies covered
  • Novartis
  • Kunming Pharmaceutical
  • Kerui Nanhai Pharmaceutical
  • Guilin Pharmaceutical Co., Ltd
  • Guangxi Xiancaotang Pharmaceutical Co., LTD
  • Sanofi-Aventis
  • KPC Pharmaceuticals, Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Coartem (Artemether & Lumefantrine) Market by Type
  3. 1.2.1 Global Coartem (Artemether & Lumefantrine) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Artemether
  5. 1.2.3 Lumefantrine
  6. 1.3 Coartem (Artemether & Lumefantrine) Market by Application
  7. 1.3.1 Global Coartem (Artemether & Lumefantrine) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Retail Pharmacy
  9. 1.3.3 Online Pharmacy
  10. 1.3.4 Hospital Pharmacy
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Coartem (Artemether & Lumefantrine) Market Dynamics
  1. 2.1 Coartem (Artemether & Lumefantrine) Industry Trends
  2. 2.2 Coartem (Artemether & Lumefantrine) Industry Drivers
  3. 2.3 Coartem (Artemether & Lumefantrine) Industry Opportunities and Challenges
  4. 2.4 Coartem (Artemether & Lumefantrine) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Coartem (Artemether & Lumefantrine) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Coartem (Artemether & Lumefantrine) Revenue by Region
  3. 3.2.1 Global Coartem (Artemether & Lumefantrine) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Coartem (Artemether & Lumefantrine) Revenue by Region (2021-2026)
  5. 3.2.3 Global Coartem (Artemether & Lumefantrine) Revenue by Region (2027-2032)
  6. 3.2.4 Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Coartem (Artemether & Lumefantrine) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Coartem (Artemether & Lumefantrine) Sales by Region
  9. 3.4.1 Global Coartem (Artemether & Lumefantrine) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Coartem (Artemether & Lumefantrine) Sales by Region (2021-2026)
  11. 3.4.3 Global Coartem (Artemether & Lumefantrine) Sales by Region (2027-2032)
  12. 3.4.4 Global Coartem (Artemether & Lumefantrine) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Coartem (Artemether & Lumefantrine) Revenue by Manufacturers
  2. 4.1.1 Global Coartem (Artemether & Lumefantrine) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Coartem (Artemether & Lumefantrine) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Coartem (Artemether & Lumefantrine) Sales by Manufacturers
  6. 4.2.1 Global Coartem (Artemether & Lumefantrine) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Coartem (Artemether & Lumefantrine) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Coartem (Artemether & Lumefantrine) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Coartem (Artemether & Lumefantrine) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Coartem (Artemether & Lumefantrine) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Coartem (Artemether & Lumefantrine) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Coartem (Artemether & Lumefantrine) Manufacturers, Product Type & Application
  13. 4.7 Global Coartem (Artemether & Lumefantrine) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Coartem (Artemether & Lumefantrine) Market CR5 and HHI
  16. 4.8.2 2025 Coartem (Artemether & Lumefantrine) Tier 1, Tier 2, and Tier 3
5 Coartem (Artemether & Lumefantrine) Market by Type
  1. 5.1 Global Coartem (Artemether & Lumefantrine) Revenue by Type
  2. 5.1.1 Global Coartem (Artemether & Lumefantrine) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Coartem (Artemether & Lumefantrine) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Coartem (Artemether & Lumefantrine) Sales by Type
  6. 5.2.1 Global Coartem (Artemether & Lumefantrine) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Coartem (Artemether & Lumefantrine) Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Coartem (Artemether & Lumefantrine) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Coartem (Artemether & Lumefantrine) Price by Type
6 Coartem (Artemether & Lumefantrine) Market by Application
  1. 6.1 Global Coartem (Artemether & Lumefantrine) Revenue by Application
  2. 6.1.1 Global Coartem (Artemether & Lumefantrine) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Coartem (Artemether & Lumefantrine) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Coartem (Artemether & Lumefantrine) Sales by Application
  6. 6.2.1 Global Coartem (Artemether & Lumefantrine) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Coartem (Artemether & Lumefantrine) Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Coartem (Artemether & Lumefantrine) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Coartem (Artemether & Lumefantrine) Price by Application
7 Company Profiles
  1. 7.1 Novartis
  2. 7.1.1 Novartis Company Information
  3. 7.1.2 Novartis Business Overview
  4. 7.1.3 Novartis Coartem (Artemether & Lumefantrine) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis Coartem (Artemether & Lumefantrine) Product Portfolio
  6. 7.1.5 Novartis Recent Developments
  7. 7.2 Kunming Pharmaceutical
  8. 7.2.1 Kunming Pharmaceutical Company Information
  9. 7.2.2 Kunming Pharmaceutical Business Overview
  10. 7.2.3 Kunming Pharmaceutical Coartem (Artemether & Lumefantrine) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Kunming Pharmaceutical Coartem (Artemether & Lumefantrine) Product Portfolio
  12. 7.2.5 Kunming Pharmaceutical Recent Developments
  13. 7.3 Kerui Nanhai Pharmaceutical
  14. 7.3.1 Kerui Nanhai Pharmaceutical Company Information
  15. 7.3.2 Kerui Nanhai Pharmaceutical Business Overview
  16. 7.3.3 Kerui Nanhai Pharmaceutical Coartem (Artemether & Lumefantrine) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Kerui Nanhai Pharmaceutical Coartem (Artemether & Lumefantrine) Product Portfolio
  18. 7.3.5 Kerui Nanhai Pharmaceutical Recent Developments
  19. 7.4 Guilin Pharmaceutical Co., Ltd
  20. 7.4.1 Guilin Pharmaceutical Co., Ltd Company Information
  21. 7.4.2 Guilin Pharmaceutical Co., Ltd Business Overview
  22. 7.4.3 Guilin Pharmaceutical Co., Ltd Coartem (Artemether & Lumefantrine) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Guilin Pharmaceutical Co., Ltd Coartem (Artemether & Lumefantrine) Product Portfolio
  24. 7.4.5 Guilin Pharmaceutical Co., Ltd Recent Developments
  25. 7.5 Guangxi Xiancaotang Pharmaceutical Co., LTD
  26. 7.5.1 Guangxi Xiancaotang Pharmaceutical Co., LTD Company Information
  27. 7.5.2 Guangxi Xiancaotang Pharmaceutical Co., LTD Business Overview
  28. 7.5.3 Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether & Lumefantrine) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether & Lumefantrine) Product Portfolio
  30. 7.5.5 Guangxi Xiancaotang Pharmaceutical Co., LTD Recent Developments
  31. 7.6 Sanofi-Aventis
  32. 7.6.1 Sanofi-Aventis Company Information
  33. 7.6.2 Sanofi-Aventis Business Overview
  34. 7.6.3 Sanofi-Aventis Coartem (Artemether & Lumefantrine) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sanofi-Aventis Coartem (Artemether & Lumefantrine) Product Portfolio
  36. 7.6.5 Sanofi-Aventis Recent Developments
  37. 7.7 KPC Pharmaceuticals, Inc
  38. 7.7.1 KPC Pharmaceuticals, Inc Company Information
  39. 7.7.2 KPC Pharmaceuticals, Inc Business Overview
  40. 7.7.3 KPC Pharmaceuticals, Inc Coartem (Artemether & Lumefantrine) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 KPC Pharmaceuticals, Inc Coartem (Artemether & Lumefantrine) Product Portfolio
  42. 7.7.5 KPC Pharmaceuticals, Inc Recent Developments
8 North America
  1. 8.1 North America Coartem (Artemether & Lumefantrine) Market Size by Type
  2. 8.1.1 North America Coartem (Artemether & Lumefantrine) Revenue by Type (2021-2032)
  3. 8.1.2 North America Coartem (Artemether & Lumefantrine) Sales by Type (2021-2032)
  4. 8.1.3 North America Coartem (Artemether & Lumefantrine) Price by Type (2021-2032)
  5. 8.2 North America Coartem (Artemether & Lumefantrine) Market Size by Application
  6. 8.2.1 North America Coartem (Artemether & Lumefantrine) Revenue by Application (2021-2032)
  7. 8.2.2 North America Coartem (Artemether & Lumefantrine) Sales by Application (2021-2032)
  8. 8.2.3 North America Coartem (Artemether & Lumefantrine) Price by Application (2021-2032)
  9. 8.3 North America Coartem (Artemether & Lumefantrine) Market Size by Country
  10. 8.3.1 North America Coartem (Artemether & Lumefantrine) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Coartem (Artemether & Lumefantrine) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Coartem (Artemether & Lumefantrine) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Coartem (Artemether & Lumefantrine) Market Size by Type
  2. 9.1.1 Europe Coartem (Artemether & Lumefantrine) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Coartem (Artemether & Lumefantrine) Sales by Type (2021-2032)
  4. 9.1.3 Europe Coartem (Artemether & Lumefantrine) Price by Type (2021-2032)
  5. 9.2 Europe Coartem (Artemether & Lumefantrine) Market Size by Application
  6. 9.2.1 Europe Coartem (Artemether & Lumefantrine) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Coartem (Artemether & Lumefantrine) Sales by Application (2021-2032)
  8. 9.2.3 Europe Coartem (Artemether & Lumefantrine) Price by Application (2021-2032)
  9. 9.3 Europe Coartem (Artemether & Lumefantrine) Market Size by Country
  10. 9.3.1 Europe Coartem (Artemether & Lumefantrine) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Coartem (Artemether & Lumefantrine) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Coartem (Artemether & Lumefantrine) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Coartem (Artemether & Lumefantrine) Market Size by Type
  2. 10.1.1 China Coartem (Artemether & Lumefantrine) Revenue by Type (2021-2032)
  3. 10.1.2 China Coartem (Artemether & Lumefantrine) Sales by Type (2021-2032)
  4. 10.1.3 China Coartem (Artemether & Lumefantrine) Price by Type (2021-2032)
  5. 10.2 China Coartem (Artemether & Lumefantrine) Market Size by Application
  6. 10.2.1 China Coartem (Artemether & Lumefantrine) Revenue by Application (2021-2032)
  7. 10.2.2 China Coartem (Artemether & Lumefantrine) Sales by Application (2021-2032)
  8. 10.2.3 China Coartem (Artemether & Lumefantrine) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Coartem (Artemether & Lumefantrine) Market Size by Type
  2. 11.1.1 Asia Coartem (Artemether & Lumefantrine) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Coartem (Artemether & Lumefantrine) Sales by Type (2021-2032)
  4. 11.1.3 Asia Coartem (Artemether & Lumefantrine) Price by Type (2021-2032)
  5. 11.2 Asia Coartem (Artemether & Lumefantrine) Market Size by Application
  6. 11.2.1 Asia Coartem (Artemether & Lumefantrine) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Coartem (Artemether & Lumefantrine) Sales by Application (2021-2032)
  8. 11.2.3 Asia Coartem (Artemether & Lumefantrine) Price by Application (2021-2032)
  9. 11.3 Asia Coartem (Artemether & Lumefantrine) Market Size by Country
  10. 11.3.1 Asia Coartem (Artemether & Lumefantrine) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Coartem (Artemether & Lumefantrine) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Coartem (Artemether & Lumefantrine) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Coartem (Artemether & Lumefantrine) Market Size by Type
  2. 12.1.1 SAMEA Coartem (Artemether & Lumefantrine) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Coartem (Artemether & Lumefantrine) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Coartem (Artemether & Lumefantrine) Price by Type (2021-2032)
  5. 12.2 SAMEA Coartem (Artemether & Lumefantrine) Market Size by Application
  6. 12.2.1 SAMEA Coartem (Artemether & Lumefantrine) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Coartem (Artemether & Lumefantrine) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Coartem (Artemether & Lumefantrine) Price by Application (2021-2032)
  9. 12.3 SAMEA Coartem (Artemether & Lumefantrine) Market Size by Country
  10. 12.3.1 SAMEA Coartem (Artemether & Lumefantrine) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Coartem (Artemether & Lumefantrine) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Coartem (Artemether & Lumefantrine) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Coartem (Artemether & Lumefantrine) Value Chain Analysis
  2. 13.1.1 Coartem (Artemether & Lumefantrine) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Coartem (Artemether & Lumefantrine) Production Mode & Process
  6. 13.2 Coartem (Artemether & Lumefantrine) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Coartem (Artemether & Lumefantrine) Distributors
  9. 13.2.3 Coartem (Artemether & Lumefantrine) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst